NCT05967754

Brief Summary

This study aimed to correlate serum uric acid levels and PAH in OSAHS patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
2.6 years until next milestone

First Submitted

Initial submission to the registry

July 15, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

August 1, 2023

Completed
Last Updated

August 1, 2023

Status Verified

July 1, 2023

Enrollment Period

2.8 years

First QC Date

July 15, 2023

Last Update Submit

July 22, 2023

Conditions

Obstructive Sleep Apnea

Outcome Measures

Primary Outcomes (1)

  • This study aimed to correlate serum uric acid levels and Pulmonary Arterial Hypertension in Obstructive Sleep Apnea Hypopnea Syndrome patients.

    This study aimed to correlate serum uric acid levels and Pulmonary Arterial Hypertension in Obstructive Sleep Apnea Hypopnea Syndrome patients.

    one Year

Study Arms (1)

Patients with Obstructive sleep Apnea

OTHER

Patients with Obstructive sleep Apnea

Diagnostic Test: polysomnography

Interventions

polysomnographyDIAGNOSTIC_TEST

polysomnography and serum uric acid measurement

Patients with Obstructive sleep Apnea

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of OSAHS by overnight polysomnography (AHI ≥ 5/ hr)
  • ≥18 years old.

You may not qualify if:

  • Other sleep disorders as narcolepsy or hypersomnia were excluded as well as Patients with neuropsychiatric disorders.
  • Hemodynamically unstable patients
  • Patients with other chronic respiratory or cardiac diseases
  • Patients with other known causes of pulmonary hypertension
  • Patients with any disease or on medication that could alter excretion or urinary metabolism of uric acid such as Excessive uric acid production

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rania Ahmad Sweed

Alexandria, 000000, Egypt

Location

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Interventions

Polysomnography

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Intervention Hierarchy (Ancestors)

Monitoring, PhysiologicDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • rania A SEWIED, doctor

    alex

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
clinical professor

Study Record Dates

First Submitted

July 15, 2023

First Posted

August 1, 2023

Study Start

January 1, 2018

Primary Completion

October 1, 2020

Study Completion

December 1, 2020

Last Updated

August 1, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations

EG(1)